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Abstract
BACKGROUND—Colorectal cancer, as the second leading cause of cancer-related deaths among 
men and women in the United States, represents an important area for public health intervention. 
Although colorectal cancer screening can prevent cancer and detect disease early when treatment 
is most effective, few organized public health screening programs have been implemented and 
evaluated. From 2005 to 2009, the Centers for Disease Control and Prevention funded 5 sites to 
participate in the Colorectal Cancer Screening Demonstration Program (CRCSDP), which was 
designed to reach medically underserved populations.
METHODS—The authors conducted a longitudinal, multiple case study to analyze program 
implementation processes. Qualitative methods included interviews with 100 stakeholders, 125 
observations, and review of 19 documents. Data were analyzed within and across cases.
RESULTS—Several themes related to CRCSDP implementation emerged from the cross-case 
analysis: the complexity of colorectal cancer screening, the need for teamwork and collaboration, 
integration of the program into existing systems, the ability of programs to use wisdom at the local 
level, and the influence of social norms. Although these themes were explored independently from 
1 another, interaction across themes was evident.
CONCLUSIONS—Colorectal cancer screening is clinically complex, and its screening methods 
are not well accepted by the general public; both of these circumstances have implications for 
program implementation. Using patient navigation, engaging in transdisciplinary teamwork, 
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assimilating new programs into existing clinical settings, and deferring to local-level wisdom 
together helped to address complexity and enhance program implementation. In addition, public 
health efforts must confront negative social norms around colorectal cancer screening.
Keywords
colorectal cancer screening; program evaluation; qualitative evaluation; interdisciplinary 
communication; early detection of cancer; cancer screening tests; collaboration; taboo; program 
implementation
INTRODUCTION
Screening for colorectal cancer, a disease that claimed over 53,000 American lives in 2007,1 
is effective in reducing both incidence and mortality.2 Screening detects disease early, when 
treatment is most effective, and screening by colonoscopy may also prevent colorectal 
cancer entirely by removing premalignant polyps.3 As the second leading cause of cancer-
related deaths among men and women in the United States,4 colorectal cancer is an 
important area for public health intervention.5 A more complete description of the colorectal 
cancer burden is found elsewhere in this supplement to Cancer.6
In 2005, the Centers for Disease Control and Prevention (CDC) initiated the Colorectal 
Cancer Screening Demonstration Program (CRCSDP) to promote colorectal cancer 
screening. Funded from 2005 to 2009, its purpose was to explore the feasibility of organized 
colorectal cancer screening programs for medically underserved populations in the United 
States.7 Across the country, 5 sites received funding: Suffolk County, New York; Baltimore 
City, Maryland; Nebraska; St. Louis, Missouri; and Greater Seattle, Washington.
As a condition of funding, sites were required to provide colorectal cancer screening for 
average risk, low-income, uninsured or under-insured adults using any test recommended by 
the US Preventive Services Task Force (USPSTF).8 In addition, recipients were mandated to 
implement other program components to support quality screening: public education and 
outreach, patient support, tracking and follow-up, quality assurance, and data monitoring. 
Sites were encouraged to develop program models best fitting the needs of medically 
underserved individuals within their localities.
To determine overall program feasibility, the CDC conducted an evaluation of the CRCSDP, 
including a longitudinal multiple case study to describe program implementation, an 
assessment of patient characteristics and clinical outcomes, and an examination of program 
costs. In the evaluation, we assessed 2 time periods—program start-up and program 
implementation. Program start-up involved the first 9 to 12 months of the project, when sites 
were hiring staff, developing policies and procedures, and putting provider contracts in 
place. The program implementation phase was the remaining project period, during which 
colorectal cancer screening services were provided. Results from program start-up, including 
a description of the 5 program models, have been published elsewhere.7,9–11
In this report, we introduce the multiple case study evaluation of the CRCSDP’s 
implementation phase. Two other articles in this supplement also draw from the case 
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study.12,13 Our purpose is to elucidate themes from the implementation of the CRCSDP to 
inform state, tribal, territorial, and other organizations planning or implementing colorectal 
cancer screening programs. Our insights into the management of colorectal cancer screening 
programs are intended to advance public health efforts and contribute to more efficient and 
effective programs in the future. We focus on 4 areas in this report. First, we discuss the 
methods of the case study. Next, we present themes that emerged during program 
implementation based on qualitative data analysis. Then, we relate these findings to the 
literature about colorectal cancer screening and compare what we observed during 
CRCSDP’s start-up. Finally, we identify limitations of the study and offer considerations 
and recommendations for the implementation of similar programs.
METHODS
We conducted a rigorous multiple case study to assess program implementation, because 
qualitative methods provide nuances of meaning, depth of understanding, and an 
ascertainment of context in analyzing complex situations and processes.14,15 Case study 
methods used for the start-up phase have been described previously.9,10 Here, we present the 
case study methods that were used to evaluate the implementation phase of the CRCSDP 
over the 4-year program period. Each of the 5 CRCSDP sites represented a single case, and 
the CRCSDP served as the overall evaluand.14,16 The longitudinal nature of the case study 
and the inclusion of all 5 cases permitted us to document and interpret what happened over 
time and to compare implementation processes across sites. By using a team approach,17,18 
we collected and analyzed information through various qualitative methods, including 
individual and group interviews, document review, and participant observation.
Sample
Each of the 5 CDC-funded CRCSDP sites represented a unique exemplar in this multiple 
case study. Each case was bound by the required program components (eg, client 
recruitment, screening and diagnostic services, quality assurance, patient support).14,16 
Within each site, evaluators selected data sources from the broadest possible range of 
individuals involved in program implementation, narrowing and focusing to fewer 
individuals in subsequent data collections as the programs moved to closure. We interviewed 
50 individuals at early implementation (from September to December 2007) and 32 
individuals while the CRCSDP was nearing the end of its funding period (from June to 
August 2009). We began with a comprehensive selection of interviewees involved with the 
CRCSDP and ended with a more purposeful19,20 sample, selecting individuals who were 
chosen for their depth of knowledge of the program. Participants in the case study included 
site staff, stakeholders, and CDC program consultants serving as liaisons between the CDC 
and site staff. Program directors at each site assisted the evaluation team in developing a list 
of potential interviewees (ie, staff and stakeholders).
Data Collection
All interviews were audio-recorded and transcribed verbatim by a professional transcription 
service. Given resource constraints, interviews in 2007 were conducted by telephone. In 
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2009, interviews were conducted in-person at each CRCSDP site. Interviewers 
supplemented the recordings with standard, structured field notes.15,21
Interview questions about program implementation centered on program successes, 
challenges, lessons learned, partnerships, staff skills, relationships with providers, and 
overall program management. Final interviews explored the program life cycle, program 
close out, and sustainability planning efforts.
The CDC case study team conducted participant observation17,22 and recorded in-field 
notes, both face-to-face and during monthly telephone conferences between the CDC 
program consultant and key site staff, including the program director, the program manager 
(sometimes the same individual), and data specialists who managed each site’s clinical data. 
We recorded field notes during the 2009 visit to each of the 5 sites and at 2 reverse-site visits 
held in 2007 and 2008, in which site personnel met together in Atlanta with CDC staff and 
national experts on colorectal cancer screening.
Our documents included the annual grantee funding applications with supporting materials 
and the subsequent reports generated by the 5 sites. Data collected during implementation 
involved reviewing 19 documents, more than 125 observations, 82 interviews with 100 
individuals (singly or in pairs), and a group interview at each of the sites.
Analysis
Data were analyzed inductively20 and abductively23,24 after each wave of interviews. 
Atlas.ti25 (version 5.6.1; Atlas.ti Scientific Software Development GmbH, Berlin, Germany), 
a qualitative analysis software program, was used to manage the material generated by the 
interviews.26 Although we used some of the concepts from the start-up analysis for the 
implementation data,12 data were distinct enough for the development of a new codebook. 
The first set of implementation data (2007) was coded by 1 team member, and a second 
member provided support when questions arose. Two members of the team shared the data 
coding for the second round of interviews (2009). Working together, the coders achieved an 
acceptable inter-rater reliability of 86%.27–32 Once coding was complete, the team identified 
common ideas among the responses of staff first within and then across the sites and 
classified codes and corresponding quotations into themes.16
Trustworthiness
Qualitative methods of data analysis are evaluated for both the research process and the 
product. Terms like trustworthiness, understanding, authenticity, and credibility are used 
interchangeably to describe what Mishler33 calls validation, a process(es) in which claims 
are made for and we evaluate the trustworthiness of reported observations, generalizations, 
and interpretations.33 The following strategies, commonly in qualitative research,17,20,34,35 
were used to establish the trustworthiness of the case study analysis: triangulation of data, 
negative case analysis, member checking, and maintenance of a detailed audit trail. We 
triangulated data collection methods through interviews, participant observation and 
document analysis, data sources across personnel at the sites, and data collectors and 
analyzers among the research team to ensure multiple positions for our research. Negative 
case analysis involves intentionally looking for cases that contradict or challenge the 
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researchers’ interpretations of the data, which results in a more nuanced and robust analysis. 
Member checking, soliciting participants’ views of the accuracy of the research findings and 
interpretations, also bolstered the credibility of our interpretations. Finally, the team 
maintained a detailed audit trail, documenting the evaluation methods and processes, to 
make our procedures explicit.
Reflexivity, or locating the researchers in the work, is another technique for enhancing the 
trustworthiness of the qualitative report.15,17 Recognizing the manner in which researchers’ 
perspectives, experiences, and values influence how data are interpreted is underscored by 
Charmaz.36 Reflexivity is used to document and track these differences.15,17,36–38 Thus, we 
note that the case study team was composed of 3 CDC evaluators (Amy DeGroff, Jennifer 
Boehm, and Elizabeth Rohan) and 2 external evaluators contracted from the University of 
Georgia (Judith Preissle and Rebecca Glover-Kudon). The evaluators have backgrounds in 
public health, education, anthropology, sociology, public policy, and oncology social work, 
providing a multidisciplinary team. Although it inevitably represented the CDC as the 
grantor to the interviewees, the team worked to minimize this power differential. With each 
round of interviews, evaluators repeated the confidentiality agreement and stressed the 
respondents’ opportunities to speak candidly about their experiences with the CRCSDP for 
the purposes of program improvement.
RESULTS
Several themes related to CRCSDP implementation emerged from the cross-case analysis: 
the complexity of colorectal cancer screening compared with screening for other cancers, 
teamwork and collaboration, integration of the program into existing systems, the ability of 
programs to use wisdom at the local level, and the influence of social norms. Figure 1 
depicts a heuristic of these themes and serves as an organizational structure for presenting 
results. The figure’s fixed form belies the fluidity of concepts within themes and between 
and among ideas. For example, a concern voiced repeatedly by participants across the sites 
was CDC’s policy to exclude from eligibility those patients who exhibited potential 
symptoms of colorectal cancer (eg, rectal bleeding). This reflected the CDC’s emphasis on a 
public health screening program for prevention and early detection in the asymptomatic 
population rather than a diagnostic or treatment program for those with symptoms. 
Nevertheless, the requirement posed challenges for site personnel at various levels of 
implementation, and the concern is mentioned repeatedly throughout the results for its 
multiple and intersecting implications. An in-depth analysis of themes on program 
recruitment, crucial to program implementation, is detailed elsewhere in this supplement to 
Cancer12 and, thus, is not included in our report.
Complexity of Colorectal Cancer Screening
Respondents across sites repeatedly commented on the multifaceted nature of colorectal 
cancer screening—the sheer complexity of it—and how that translated into complexity in 
implementing their screening programs. Although many factors contribute to the complexity 
of colorectal cancer screening, those aspects identified most frequently in CRCSDP’s 
implementation were the multiple types of tests available to screen for colorectal cancer, the 
Rohan et al. Page 5













assessment of whether a prospective candidate for screening already was exhibiting potential 
colorectal cancer symptoms, and, for patients, the overall difficulty of completing colorectal 
cancer screening.
Multiple screening test types available—Although medical screenings for most other 
cancers depend on a single type of test, colorectal cancer screening can be accomplished 
through a single test or a combination of tests, including colonoscopy, fecal occult blood test 
(FOBT), fecal immunochemical test (FIT), sigmoidoscopy, computed tomography (CT) 
colonography, and fecal deoxyribonucleic acid (DNA) testing. CRCSDP sites were required 
to use any screening method recommended by the USPSTF. At the time the program started, 
these included annual FOBT, sigmoidoscopy, or double-contrast barium enema every 5 years 
or colonoscopy every 10 years.8 Three sites initially selected FOBT (followed by 
colonoscopy for those with FOBT-positive results), and 2 sites chose colonoscopy. 
Complicating matters, a patient’s risk for colorectal cancer has implications for the type of 
screening test used. At all CRCSDP sites, patients were assessed for risk (eg, family history 
of colorectal cancer, personal history of polyps) at enrollment; and, for FOBT programs, 
those patients deemed high risk were referred directly to screening colonoscopy.
The variety of screening tests added to the complexity of implementing the CRCSDP in 2 
ways. First, as noted above, each program chose among 4 different test types and dealt with 
the sequelae of their choice(s). For some sites, their test choice made CRCSDP 
implementation more laborious. For example, some sites observed that, counterintuitively, 
their choice of FOBT—a simpler test—was administratively more complicated. A program 
manager from the health department explained that, although patients in her state’s CDC-
funded National Breast and Cervical Cancer Early Detection Program (NBCCEDP) could be 
enrolled in a variety of ways, the complexity and burden of determining the appropriate test 
type for the colorectal cancer program necessitated a single point of entry—the health 
department—because they believed it was too burdensome to be handled in a primary care 
practice. She said, “It’s because (we’ve) got to apply the (eligibility) algorithms that actually 
are kind of complicated. How does that look for a physician’s office?”
Site staff also observed that the general public was confused about the variety of test types 
available and reported that patients did not always understand why they were being offered a 
particular test. A staff member from a site that was using FOBT described how community 
uncertainty about the various screening tests challenged their program. She said:
“So, when you say colon cancer screening, 1 of 3 things happens. 1) They interpret 
it as a colonoscopy, so they don’t call in (to enroll), because they are scared; 2) they 
interpret it as colonoscopy, and they are okay with (having 1, but, when) they call 
in, they get an FOBT kit, and then they are angry; or 3) they call in saying they 
don’t know what (colorectal cancer screening) is, and FOBT gets explained to 
them. So … some people were complaining about false advertisement. They were 
assuming that a colon cancer screening was a colonoscopy when there are 
(actually) several techniques that can be done.”
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Complexity in assessing potential colorectal cancer symptoms—Assessing 
whether a patient exhibited colorectal cancer symptoms also contributed to the complexity 
of implementation, because symptoms of colorectal cancer (eg, rectal bleeding, abdominal 
pain, a change in bowel habits, and weight loss) can be difficult to distinguish from 
symptoms of other conditions. This site staff member explained, “Vague, smaller symptoms 
(are usually) symptoms of hemorrhoids, because technically, a little blood on the tissue 
(toilet paper) generally is going to be a hemorrhoid.”
One of the CDC’s program policies, as stated above, deemed individuals who were assessed 
as symptomatic for colorectal cancer ineligible for the CRCSDP. Consequently, sites 
developed complex algorithms for determining clinical eligibility for patients, posing 
implementation challenges for 4 of the 5 sites. The policy had repercussions for how sites 
approached—and often struggled with—assessing clinical symptoms, providing general 
public education about the program, recruiting patients for the program, and addressing the 
concerns of clinicians who were troubled by this policy.
The Suffolk County site in New York worked around the complexity of symptom assessment 
and, thus, did not struggle with the ramifications of the policy. Rather than relying on 
multiple providers at the community health centers—in which clients were recruited to 
assess patients for clinical eligibility—this site had a physician on its team who conducted 
the assessment for clinical eligibility on all patients who were referred to the program. The 
physician’s clinical expertise facilitated the assessment process, including identifying 
medical resources for clients who were deemed ineligible for the CDC-funded program. A 
site staff member said the following:
“We needed someone with medical skills to handle the precolonoscopy (telephone) 
assessment in terms of identifying any potential medical ineligibility and making 
sure (to) refer (patients who are not eligible) to the appropriate source. … This 
individual, in our case, is a physician. I think … a nurse practitioner or a PA 
(Physician Assistant) could be trained to do it.”
Patients’ difficulties with completing colorectal cancer screening—Finally, 
patients’ difficulties in completing any of the screening tests made the process complex. This 
was especially true for colonoscopy, which can involve a patient’s having a precolonoscopy 
medical examination, taking time off work the day before the colonoscopy to prepare (ie, 
“prep” or clean out) the bowel, taking time off work for the colonoscopy itself, and 
arranging for an escort to and from the procedure. As a staff member at a site exclusively 
using colonoscopy said, “We’ve learned to appreciate, to use the term loosely, just how 
complicated it is … to get 1 person through the program.” Understanding these difficulties, 
the CDC required sites to provide support services for patients to facilitate the screening 
process.
On the basis of community needs, each site defined its own approach to providing patient 
support. The comprehensiveness of these services ranged from using health department staff, 
to providing little more than telephone reminders with patients at 1 site, and to providing a 
dedicated, full-time patient navigator at another site.39 More intensive support services, that 
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is, patient navigation, were used more often for patients undergoing colonoscopy than for 
those completing FOBT. To assist patients with their colonoscopies, navigators provided 
education about colorectal cancer screening and the bowel preparation process, ensured that 
patients had access to laxative supplies, conducted reminder and follow-up calls, assisted 
with logistical barriers, and served as liaison between the patient and clinical staff. A staff 
member who was discussing the difficulty patients had with colonoscopy procedures 
claimed that, “Patient support services make or break the program.”
It is noteworthy that patient support services helped the CRCSDP reach its intended 
population—the medically underserved. Navigators, by garnering the trust of patients, 
provided a conduit to the medical system for populations who otherwise did not have access 
to primary care. A site staff member explained, “In the population we’re serving, in an urban 
setting … there’s not a natural trust (in) the hospital or the medical system.”
This issue of complexity is central to understanding the CRCSDP’s implementation. 
Interviewees noted that they had significantly and continually underestimated how much 
time, staff, and overall effort were needed to implement the program. Although 
underestimating effort may be typical of any new program, the seasoned health care 
providers across the CRCSDP sites agreed on the unique complexity of colorectal cancer 
screening.
Teamwork and Collaboration
Teamwork is essential in clinical oncology care,40–43 and collaboration was evident at each 
of the 5 CRCSDP sites. Three aspects of working together to enhance program 
implementation emerged from the data: a high-functioning team, designated program staff, 
and collaborative partnerships.
High-functioning team—Having a high-functioning team was essential for implementing 
the CRCSDP. For our purposes, “team” refers to site staff, that is, the group of staff within 
the grantee agency leading the CRCSDP. Staff across sites described a high-functioning 
team as exhibiting “good communication skills, teamwork, team building, encouraging and 
supporting 1 another, validating successes, and (discussing) problems … in a way that 
preserves the integrity of the people who are involved.” Data suggest that high-functioning 
teams with diverse expertise were key to implementing the CRCSDP, given its complexity. 
Effective implementation demanded coordination among staff with varied, but 
complementary, experience and expertise: for example, clinical aspects of colorectal cancer 
screening, health education, data management, and contract management. Site staff 
recognized the necessity for an interdisciplinary approach: “Each team member brought (his 
or her) own skills and abilities to the broader program.”
Although team structures varied across sites—from hierarchical to horizontal—role 
definition, a well defined division of labor, and clear communication were indispensable to 
team functioning. Sites also benefited from teams of consistent, tenured staff. Four of the 5 
sites had almost no turnover during the 4-year program period, enhancing team cohesion and 
supporting the development of institutional program knowledge.
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The notion of teamwork—which became more pronounced over time—was so critical to 
implementation that, when asked to identify program champions, site staff were reluctant to 
name just 1 individual. Instead, they named the whole team, indicating a shared 
responsibility for and commitment to the program’s success: “Not 1 person is responsible 
for all of this … It takes a team of people to understand it, to work together, and be 
committed to it.”
Designated program staff—Participants emphasized the necessity of having 1 or more 
designated staff, as part of their teams, fully funded by the program to implement the 
CRCSDP. They noted the substantial effort required to implement a brand new public health 
program. However, for multiple reasons—hiring restrictions, efforts to integrate staff across 
several public health programs, and preserving program funding for screening services—
several sites initially relied on existing staff to administer the CRCSDP. Some of these staff 
members were assigned part time to the CRCSDP, and others were supported entirely with 
non-CDC resources but were assigned to the CRCSDP in addition to their other 
responsibilities.
Consequently, some staff felt pulled in several directions when working across multiple 
public health programs. Site staff emphasized that, at times, the CRCSDP was all-
consuming, rendering them unable to meet their other responsibilities. Conversely, staff 
reported feeling compromised in their efforts to implement the CRCSDP while working for 
other programs. One site staff member described the day-to-day angst of the staffing 
arrangement: “I would probably say half my day is spent on … (CRCSDP).… It’s turned out 
to be a lot (of work), and I still have 2 other full-time jobs I have to deal with.” Some sites 
adjusted staffing plans by hiring full-time individuals for the CRCSDP. For other sites, 
resource constraints limited the capacity to make staffing changes, and they struggled with 
this dilemma over the 4 years.
Designated staff also were integral to program implementation at local provider sites where 
screening services were delivered. Provider sites were typically overburdened community 
health clinics, university hospitals, or specialty clinics facing significant resource limitations 
and patient populations with extensive needs. Without a designated staff member within a 
provider site to champion the program and facilitate its integration there, implementation 
could easily falter. Over time, the Greater Seattle, Baltimore City, and St. Louis sites 
benefited from recruiting and financially supporting some level of staffing within the 
provider sites. One provider site staff member said, “If you’re going to have facilities doing 
the screening, there needs to be a person of some sort, I don’t care (what the role is), but a 
contact person (onsite).” Funding staff in these clinics fostered clinic-level program 
integration and ensured oversight and accountability.
Collaborative partnerships—Collaboration with external partners advanced CRCSDP 
implementation by extending program resources and increasing legitimacy. Some 
relationships with partners were formalized through memoranda of understanding, whereas 
others remained informal. Overall, staff were adamant that, “you can’t do this (program) in a 
vacuum.”
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To extend resources beyond what the program itself could provide, sites needed to work with 
other agencies. For example, collaborative partnerships were essential in meeting the CDC’s 
mandate to secure resources for treatment of patients diagnosed with cancer through the 
CRCSDP. In Nebraska, cancer centers across the state committed to providing cancer 
treatment resources through written memoranda of understanding. Partners supported other 
program components as well—the Baltimore City site involved the American Cancer 
Society’s call center to field questions about the program and assist with client recruitment. 
Leveraging such partnerships extended program resources and enhanced program 
implementation. State Comprehensive Cancer Control (CCC) Programs helped foster these 
partnerships. A site staff member remarked that, “Having a really good relationship with the 
CCC Program has been absolutely critical in (our state).… (The CCC Program director) has 
so many contacts in the cancer world in the state, and she’s really pulled a lot of things 
together for us.
Partnerships also advanced the program’s stature in the community, providing both tacit and 
active endorsement and furthering the program’s credibility among a wider audience. For 
example, medical advisory boards often included well respected leaders in the field of 
colorectal cancer who actively promoted and implemented the CRCSDP. In 1 site, a leading 
gastrointestinal surgeon made presentations to physicians across the state about the value 
and effectiveness of FOBT. Several sites also were able to enlist colorectal cancer survivors 
as partners to endorse their programs, providing personal testimonials to promote colorectal 
cancer screening.
Across sites and circumstances, site staff discussed how teamwork and collaborative 
partnerships were essential to CRCSDP implementation. Cooperation among members of a 
high-functioning team, having funded staff in key roles, and collaborating with partners to 
extend the reach or resources of the program were crucial.
Integration into existing systems—The CRCSDP, as a new program, was integrated 
into existing social organizations and structures, or systems, while maintaining a distinct 
program identity.13 Throughout the course of the program, sites achieved various degrees of 
integration into local, existing systems.
Integration into existing public health programs—To establish the CRCSDP, 4 of 
the 5 sites built on their NBCCEDP, capitalizing on existing program infrastructure, such as 
experienced staff, provider and partner networks, and data management systems. Such 
integration benefited the CRCSDP sites by facilitating implementation; however, instances 
occurred in which integration proved problematic, suggesting the necessity for a more 
careful consideration of the degree to which integration with existing public health programs 
was both feasible and desirable.
One example of sites’ use of existing infrastructure to support implementation was the 
established network of NBCCEDP providers and partners, which offered a ready pool of 
familiar (or well known) primary care providers. Respondents claimed that building on these 
existing relationships helped the CRCSDP gain legitimacy in the medical community and 
fostered provider interest in working with this new program. One site staff member said, 
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“Our breast and cervical health program … has a good reputation in the medical community 
here, so the partnership (with the NBCCEDP) has been really helpful.” A staff member from 
another site explained that the willingness of their providers to work with the CRCSDP 
hinged on the trusting relationships they had built over the course of the NBCCEDP: “I think 
a lot has to do with (the fact that) they trust the program. We’ve been around for a long time, 
and they know they can trust us with breast and cervical, and so I think maybe that has 
helped.”
Nevertheless, integration with existing programs did not always facilitate implementation. 
This was especially evident with the CRCSDP policy that excluded symptomatic patients, 
because the NBCCEDP allows symptomatic women to be served. Across sites, staff 
repeatedly commented on the difficulty of integrating programs, including promoting the 
CRCSDP and the NBCCEDP together, given the discrepancy in eligibility criteria between 
the 2 programs, as the following quote indicates:
“It’s kind of hard for providers to wrap their heads around (the idea) that, with this 
program, we can’t enroll symptomatic clients. But, in the breast and cervical, if you 
have a symptomatic client, that’s when you really rev up and work and get a 
resolution to that abnormality.”
In some instances, integration across screening programs led to confusion among clients and 
providers. Nebraska’s Every Woman Matters program integrated the CRCSDP with 2 other 
CDC-funded programs: the NBCCEDP and Well Integrated Screening and Evaluation for 
Women Across the Nation (WISEWOMAN), which focuses on cardiovascular health. 
Although site staff promoted the 3 programs together, they needed to ensure that patients 
and providers understood that the programs were, indeed, distinct. One Nebraska site staff 
member noted, “(Patients) have confusion, sometimes, if they are clients of the Every 
Woman Matters program. They think they’re automatically enrolled in the colorectal 
program.” Providers are often similarly confused.
The program in Suffolk County, New York was a stand-alone program that did not integrate 
with other programs within their system. Still, this program achieved a great deal of success 
and provides a counter-example to the models of integration described above.
Integration into clinical settings—Site staff members’ understanding of provider sites’ 
systems and processes, such as patient flow processes, data collection systems and related 
forms, and treatment plans, was fundamental to integrating the CRCSDP into those clinical 
settings. Some of this expertise was gained from each program’s medical advisory board, 
which was convened by the sites during start-up to provide clinical guidance. In addition, 
some site staff had first-hand clinical knowledge and experience, which augmented 
integration of this public health program into clinical settings. This site staff member 
described how he used his knowledge of clinical settings to empathize with provider site 
staff:
“Well, I think (it’s important) definitely to work within the existing clinical systems 
as much as you can. By that I mean when I go out to the different clinics or when 
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I’m training new clinicians on this program, I think I use my experience (of having) 
work(ed) in a clinic to relate to them that I understand the mindset.”
Supporting integration into clinical settings (eg, provider sites) exemplifies the flexibility 
CRCSDP sites built into their programs, a pattern emphasized in the section below. 
Integration of the CRCSDP into existing systems, although fundamental to furthering 
program implementation, took time, demanded careful consideration, and required support.
Wisdom at the local level: In vivo theme—Wisdom at the local level was a theme that 
emerged from the data in vivo, that is, derived directly from respondents’ own words. One 
site staff member described the CRCSDP as “a marvelous program, if we could just loosen 
up some of the (CDC-imposed) criteria and (be) allow(ed to use) some wisdom at the local 
level (we’d be even better off).” Site staff appreciated having flexibility at the program level 
and being able to use their knowledge of the local environment to enhance program 
implementation. Most staff wished for the clinical autonomy to incorporate local wisdom.
Flexibility at the program level—Because the CRCSDP was a demonstration program, 
the CDC permitted flexibility across sites for many aspects of implementation, including the 
program models used, screening test type(s) selected, and overall program management. 
Staff across all sites commented that it was useful to have “enough flexibility to let go of 
things that weren’t necessary” and to change things that were not working. Site staff also 
noted the importance of “tailor(ing) what they’re doing to their own situation, their own 
resources, their own strengths.” This flexibility, intentionally built into the CDC’s design of 
the CRCSDP, was mirrored at sites with decentralized programs (Baltimore City, Greater 
Seattle, and St. Louis) that contracted with multiple provider sites to offer screenings. Staff 
from these sites realized that their program designs and implementation activities needed to 
be “flexible so that (they could) provide for the context of each provider.” This flexibility at 
the provider site level corresponded to the flexibility at the program level of the CRCSDP.
Conversely, many site staff aspired for greater flexibility at the program level on clinical 
eligibility, because they disagreed with the CDC’s policy of excluding symptomatic patients. 
One site staff member explained that the population their program intended to serve was 
particularly vulnerable to experiencing gastrointestinal symptoms because of their life 
circumstances, including challenges of communicating across diverse cultural expressions of 
pain:
“(Excluding people with symptoms) is … not optimal. The reality is our patient 
population is stressed, low income, uninsured, multiethnic—and half of them have 
abdominal symptoms. (These symptoms are) so common that (the policy) excludes 
(a lot of people who need to be screened).”
Knowledge of local culture—Site staff’s knowledge of local cultures was evident both 
in program models and in implementation activities. For example, Nebraska’s program 
offered limited support services to patients to help them through the screening process. In 
explaining that the state is comprised of many small towns with a deep-rooted culture of 
neighbors helping each other, site staff repeatedly noted, “Nebraskans will help 
Nebraskans.” In their view, the health department had less need to provide logistical support 
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to patients in that program. In addition, Nebraska patients were asked to contribute a small 
fee for their colonoscopies so that the CDC resources could be used to screen more people, 
which paradoxically reflects both the neighbors-helping-neighbors culture and the self-
sufficiency culture in that state. A site staff member from Nebraska explained that their 
patients took pride in paying the fee.
Site staff in Greater Seattle also described how they considered local cultures in designing 
their program, as this comment illustrates:
“From my perspective working out of the local County Public Health Department, 
the more local you can make programs like this work (and) the more you can build 
up the fabric of your community long term, the better off you’re going to be, 
because you are building up from within the communities and not trying to impose 
it on top. I think especially in our state, (which) tends to (favor) local control 
anyway, the idea that you would have a state health department tell somebody here 
in Seattle what to do and how to do it just doesn’t seem to make sense to me.”
During the course of CRCSDP implementation, the Greater Seattle program introduced a 
shared decision-making model that they believed was more consistent with their community 
culture and, consequently, would be more effective in recruiting clients. This model was 
intended to encourage a discussion between patient and provider about whether the patient 
preferred FOBT or colonoscopy, as opposed to having providers impose a particular test. 
The shared decision-making model resonated with the local control, grass-roots culture of 
Greater Seattle, as described previously.
Clinical autonomy—More clinical autonomy was desired for 2 clinical decisions—
establishing the colonoscopy rescreening interval and allowing individuals who had 
symptoms into the program. Site staff were occasionally confronted with endoscopists who 
prescribed a shorter interval for rescreening than recommended by the USPSTF guidelines8 
followed by the CDC. In these situations, site staff and provider site coordinators, many of 
whom were nurses, described feeling uncomfortable with questioning a gastroenterologist’s 
decision while trying to enforce CDC program guidelines. At times, adhering to program 
policies meant challenging a physician’s clinical autonomy, a difficulty of CRCSDP 
implementation.
In addition, site staff wished for more clinical autonomy to allow symptomatic patients into 
the program. Site staff expressed frustration with being responsible for implementing a 
policy they did not like, as noted above; concomitantly, many providers struggled with the 
stifled autonomy. They wished to include patients with “certain (potential colorectal cancer) 
symptoms” given their clinical and ethical sensibilities. One site staff member described the 
difficulty clinicians—both primary care providers and gastroenterologists—had with 
excluding symptomatic patients:
“(There was) tremendous pushback from providers about not being able to see 
symptomatic people. … It was a hurdle for us to get over as far as getting providers 
to buy into doing this program. … It just runs contrary to a provider’s nature when 
you exclude people who are symptomatic.”
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Overall, these data suggest that allowing sites to use their local wisdom can enhance 
implementation by supporting responsive, strengths-based management. Many professionals 
at each CRCSDP site had years of experience working with patients in their communities. 
They not only wanted their knowledge to be recognized and respected, but they also wanted 
to use what they knew to be good practice. They wanted to be empowered to use this 
knowledge, that is, “wisdom at the local level,” to implement the CRCSDP.
Social Norms
Although it was not a factor that was considered much at the outset, by the end of the 
CRCSDP, site staff reflected on the effect of social norms on the implementation and 
performance of their programs. The predominant social norms repeatedly confronted by site 
staff were the taboos associated with colorectal cancer screening procedures and the 
perception of many individuals that the screening tests are embarrassing and unpleasant. 
These norms mean that colorectal cancer screening is not as widely accepted—or discussed 
among friends—as are other cancer screening tests. One site staff member conceded, “There 
isn’t the level of community support (for colorectal cancer) like (there is) for breast cancer.”
The taboo associated with colorectal cancer screening procedures—The taboo 
site staff described ranged from their awkwardness with discussing stool to patients’ 
aversion to colonoscopy because of homophobia or a history of sexual abuse. The taboo was 
reflected in reluctance among some site staff and primary care providers to speak frankly 
with patients about colorectal cancer screening. Repeatedly, respondents described 
awkwardness in directly discussing bowel movements with patients. One site staff remarked: 
“I was really embarrassed. I was calling the patient up, and I didn’t really quite know how to 
say your stool. Do you talk about stool? Do you talk about bowel movements? Do you call it 
poop?” Another site staff member described similar discomfort from staff at a provider site, 
which prompted them to provide training to their staff, “The medical assistants for a while 
were, like, ew (gross), I don’t want to talk about that with the patient.”
Some respondents described a stronger reaction, explaining the taboo around having 
something inserted into the anus, particularly for men. One site staff member focused on 
homophobia: “I think they find (colonoscopy) frightening … and something that they don’t 
consider wholesome or correct.” Another directly and poignantly addressed the aversion to 
colonoscopy because of an individual’s history of sexual abuse:
“I think it’s a huge sexual taboo, and it’s not even talked about. No one (from our 
program) has once raised the idea that putting something up another’s rectum 
implies sodomy abuse. And so, to talk with someone who has suffered sexual abuse 
and explain what colonoscopy is … and that they’re getting anesthesia (and going 
to be asleep), they’re absolutely terrified (about) what’s going to happen and that 
they’re not in control. I have had 2 transgender patients, and, you know, their 
stories are very complex. I met them down there (in the colonoscopy suite) and 
literally held their hand(s) while they went to sleep.”
As site staff came to recognize the impact of the taboo associated with colorectal cancer 
screening, they confronted it more directly. They emphasized that the CRCSDP forced the 
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issue of talking about body parts associated with colorectal cancer screening, which, in turn, 
decreased the stigma associated with the taboo. One site staff claimed, “(Colorectal cancer 
screening messages are) all over the place now … from me, from the providers, and so 
everybody’s a lot more comfortable about the whole issue.”
The “ick factor” associated with colorectal cancer screening—Related to the 
taboo about colorectal cancer screening is the public’s perception that such screening 
procedures are embarrassing and unpleasant, prompting the “ick factor.” Site staff suggested 
that many individuals avoid colorectal cancer screening because they are reluctant to deal 
with their stool directly in an FOBT or indirectly by using laxatives to clean out their bowels 
in preparation for colonoscopy. One respondent described what she observed as the general 
public’s perception of FOBT, saying, “People don’t want to do (FOBT). They’re messy. 
They think, oh, I have to smear my stool … and they don’t (want to do it). I think it’s 1 of 
those gross factors that they don’t want to deal with.”
Overall, site staff noted that social norms around colorectal cancer screening discouraged 
screening, affecting not only how sites recruited clients to the program12 but also how staff 
interacted with patients once enrolled. Site staff did concede, however, that both widespread 
acceptance of breast cancer screening and the existence of the CRCSDP have helped to 
increase the social acceptability of colorectal cancer screening. This site staff member 
compared previous shifts in social norms about breast cancer screening to currently shifting 
social norms about colorectal cancer screening:
“Let’s look at the general public. People just aren’t getting screening for colon 
cancer, whether they have insurance or they don’t. … I certainly lived in an era 
when women started getting mammograms, and it took us a while to decide that 
was something we wanted to do. It was painful. It had stigma. You didn’t talk about 
that part of your body.”
Challenging the social norms that undermine the social acceptability of colorectal cancer 
screening was imperative to successful CRCSDP implementation, a concept that developed 
throughout the course of the program.
DISCUSSION
Several interacting themes emerged from the cross-case analysis with implications for 
implementing the CRCSDP. Notably, the technical features of colorectal cancer screening 
contribute to its complexity. However, social norms, including taboos around human 
eliminatory functions and the “ick factor” in the screening procedures, interact with the 
clinical complexity to further complicate program implementation. Moreover, because both 
clinicians and the general public are susceptible to these social norms, addressing the 
provider-patient interaction may be necessary to enhance not only patient care but also 
implementation of colorectal cancer screening programs. Similarly, local wisdom may be 
applied in making decisions about program policies and integrating colorectal cancer 
screening into existing clinical systems and public health programs. Teamwork and 
collaboration interact with each of the other themes, because those are the mechanisms 
through which the work is accomplished. In documenting program implementation 
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processes, our results elaborate on issues raised in extant literature on colorectal cancer 
screening2,3,44–59 and offer valuable insights into other clinical and public health 
professionals who aim to advance colorectal cancer screening more broadly.
The themes from our analysis have implications for practice. These data suggest that the 
overall complexity of colorectal cancer screening is a function of many factors that are not 
readily simplified, and implementation of the CRCSDP reflected this complexity in both 
planning7,10 and delivery. Site staff, as noted above, had underestimated the complexity 
involved in colorectal cancer screening and, thus, had significantly and continually 
underestimated how much effort was needed to implement the CRCSDP. To help manage the 
complexity of implementing a colorectal cancer screening program, public health 
practitioners, clinicians, and other stakeholders must be empowered to use their “wisdom at 
the local level” throughout program implementation. Specifically, programs could use their 
wisdom and knowledge of the local cultures to provide education to the public about the 
variety of test types available for colorectal cancer screening and to promote shared decision 
making between providers and patients to accommodate patients’ test preferences. In 
addition, these data indicate that incorporating patient navigation services (or similar patient 
support services) into the CRCSDP helped patients traverse the complicated terrain of 
colorectal cancer screening, supporting similar findings from previous 
research.39,47,51,54,60,61
These data also suggest that a transdisciplinary approach to the implementation of a complex 
public health program like the CRCSDP is preferable to multidisciplinary or 
interdisciplinary approaches. Multidisciplinary models of practice involve bringing together 
practitioners from different disciplines to work on a particular project or program, yet each 
practitioner views the issue within his or her own disciplinary framework.62–64 
Interdisciplinary practice goes a step further, integrating different perspectives; however, 
practitioners remain grounded in their own disciplines.62–64 Building on both 
multidisciplinarity and interdisciplinarity, transdisciplinary teamwork transcends 
disciplinary boundaries to accommodate complexity and create new conceptual frameworks 
from which to understand and resolve issues on the task or process at hand.62–66 The goal of 
transdisciplinarity is to gain an understanding of the world in its complexity and not just a 
part of it.62 The high-functioning teamwork described by CRCSDP site staff was 
transdisciplinary. CRCSDP team members—and their collaborating partners—came to the 
program with different disciplinary backgrounds, but they transcended those boundaries to 
design, implement, and address difficulties in a complex public health program. By 
practicing transdisciplinary public health, practitioners, researchers, and evaluators can 
identify and address the complexities inherent in implementing a complex program like the 
CRCSDP.
Furthermore, these data suggest that successful implementation of screening for 1 type of 
cancer (eg, breast cancer) may not assure success in colorectal cancer screening. While 
capitalizing on existing program infrastructure often enhances the implementation of a new 
public health program, especially during the start-up phase,9 it cannot be assumed that 
wholesale integration is feasible or even preferable. While integration has been emphasized 
in public health, including for chronic diseases,67 careful consideration must be given to the 
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similarities and differences between and among programs. Assimilation—not necessarily 
integration—may be a more meaningful goal. Integration means combining different 
programs; assimilation means preserving distinct programs as they become part of a larger 
whole. In this way programs can maximize efficiencies and capitalize on their experience 
while maintaining separate policies and procedures, where needed, and adequate staffing for 
carrying out a new program. This conception of assimilation can help inform other public 
health or other health care programs intending to integrate cancer screening or other chronic 
disease programs.
Finally, the influence of social norms on the uptake of colorectal cancer screening cannot be 
underestimated. Our data suggest that social norms about feces68 and the processes involved 
in colorectal cancer screening,44,45,49,50 particularly colonoscopy, tend to be negative and, 
thus, undermine more widespread colorectal cancer screening. Previous research asserts that 
a screening test has to be acceptable both to the target population and to health care 
professionals.69,70 If social norms associated with colorectal cancer screening procedures 
are not addressed, then they remain a strong, invisible force against improved screening 
prevalence. Consequently, public health efforts, including policy initiatives and national 
campaigns, such as Screen for Life, must contribute to shifting social norms and normalizing 
colorectal cancer screening. Advancing social norms about colorectal cancer screening 
requires transdisciplinary teamwork grounded in an ecologic model71 that recognizes the 
influence of multiple sectors, including families, primary care providers, faith-based 
organizations, workplaces, health care institutions, private and public insurers, media, and 
policy makers.
Like in any qualitative inquiry, our findings are not statistically generalizable to other 
settings. Although the results are specific to these 5 unique cases, our analysis provides 
sufficiently detailed documentation to allow readers to decide on the naturalistic 
generalizabilty16 (ie, transferability) of the findings to their own settings.20 In addition, our 
results do not include patients’ views of the CRCSDP or attitudes from the communities that 
were served by the programs, nor do we have input from site staff who left their positions. 
To mitigate these limitations, we used rigorous methods, including studying each of the 5 
sites intensively, performing member checks, and generating continual documentation across 
time. Furthermore, we considered competing explanations for the patterns we developed, 
and our reports have been scrutinized by experts in public health who were not directly 
involved in the study. Finally, 3 of the 5 evaluators were from the CDC, which may have 
influenced the responses from participants either to present a more positive view of the 
program or to speak less candidly about problems that arose. However, such “insider” effects 
were moderated by the inclusion of 2 external evaluators. In addition, because respondents 
appeared to be as willing to speak candidly about problems and challenges as they were to 
speak about successes, we believe that any “insider” effects were inconsequential. These 
case study results provide depth to our understanding of the myriad issues CRCSDP staff 
addressed during implementation that augments the quantitative evaluations provided 
elsewhere in this supplement to Cancer.6,11,72
The CRCSDP, as a demonstration project, offered a unique opportunity to evaluate the 
implementation of a novel public health program. Our results provide valuable insights for 
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the implementation of similar efforts in the future. Although some of the implementation 
issues faced by the CRCSDP were unique to colorectal cancer screening, many of the 
themes we identified may be applied to other types of screening programs and perhaps to 
other chronic disease programs.
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Implementation themes that emerged from cross-case analysis are illustrated. Those themes 
include the complexity of colorectal cancer screening, team work and collaboration, 
integration into existing systems, wisdom at the local level, and the influence of social 
norms.
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